Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashish Goyal

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Pulmonary Pharmacology & Therapeutics|December 4, 2019
Real-world evaluation of the clinical safety and efficacy of fluticasone/formoterol FDC via the Revolizer® in patients with persistent asthma in IndiaAloke Ghoshal, Pradyut Waghray, George Dsouza, et al.
Cell Cycle (Georgetown, Tex.)|April 11, 2018
Reactivation of endogenous retroviral elements via treatment with DNMT- and HDAC-inhibitorsMichael Daskalakis, David Brocks, Yi-Hua Sheng, et al.
Arxiv|June 12, 2026
Modeling hepatitis D virus kinetics during bulevirtide monotherapy: challenges and solutionsAdquate Mhlanga, Louis Shekhtman, Ashish Goyal, et al.
Viruses|October 26, 2021
Mathematical Modeling of Vaccines That Prevent SARS-CoV-2 TransmissionDavid A Swan, Ashish Goyal, Chloe Bracis, et al.
Leukemia|July 14, 2025
DNA demethylation-mediated downregulation of MNX1 in acute myeloid leukemiaSimge Kelekçi, Katherine Kelly, Ashish Goyal, et al.
Nucleic Acids Research|October 31, 2021
ID3 promotes homologous recombination via non-transcriptional and transcriptional mechanisms and its loss confers sensitivity to PARP inhibitionAli Bakr, Joschka Hey, Gianluca Sigismondo, et al.
Haematologica|January 12, 2023
TAL1 activation in T-cell acute lymphoblastic leukemia: a novel oncogenic 3' neo-enhancerCharlotte Smith, Ashish Goyal, Dieter Weichenhan, et al.
Cancers|June 2, 2021
Epigenetic Modulation of Radiation-Induced Diacylglycerol Kinase Alpha Expression Prevents Pro-Fibrotic Fibroblast ResponseChun-Shan Liu, Reka Toth, Ali Bakr, et al.
Molecular Cancer|January 17, 2023
Harnessing the MYB-dependent TAL1 5'super-enhancer for targeted therapy in T-ALLCharlotte Smith, Aurore Touzart, Mathieu Simonin, et al.
Leukemia|March 23, 2023
Translocation t(6;7) in AML-M4 cell line GDM-1 results in MNX1 activation through enhancer-hijackingDieter Weichenhan, Anna Riedel, Charlotte Meinen, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Pulmonary Pharmacology & Therapeutics|December 4, 2019
Real-world evaluation of the clinical safety and efficacy of fluticasone/formoterol FDC via the Revolizer® in patients with persistent asthma in IndiaAloke Ghoshal, Pradyut Waghray, George Dsouza, et al.
Cell Cycle (Georgetown, Tex.)|April 11, 2018
Reactivation of endogenous retroviral elements via treatment with DNMT- and HDAC-inhibitorsMichael Daskalakis, David Brocks, Yi-Hua Sheng, et al.
Arxiv|June 12, 2026
Modeling hepatitis D virus kinetics during bulevirtide monotherapy: challenges and solutionsAdquate Mhlanga, Louis Shekhtman, Ashish Goyal, et al.
Viruses|October 26, 2021
Mathematical Modeling of Vaccines That Prevent SARS-CoV-2 TransmissionDavid A Swan, Ashish Goyal, Chloe Bracis, et al.
Leukemia|July 14, 2025
DNA demethylation-mediated downregulation of MNX1 in acute myeloid leukemiaSimge Kelekçi, Katherine Kelly, Ashish Goyal, et al.
Nucleic Acids Research|October 31, 2021
ID3 promotes homologous recombination via non-transcriptional and transcriptional mechanisms and its loss confers sensitivity to PARP inhibitionAli Bakr, Joschka Hey, Gianluca Sigismondo, et al.
Haematologica|January 12, 2023
TAL1 activation in T-cell acute lymphoblastic leukemia: a novel oncogenic 3' neo-enhancerCharlotte Smith, Ashish Goyal, Dieter Weichenhan, et al.
Cancers|June 2, 2021
Epigenetic Modulation of Radiation-Induced Diacylglycerol Kinase Alpha Expression Prevents Pro-Fibrotic Fibroblast ResponseChun-Shan Liu, Reka Toth, Ali Bakr, et al.
Molecular Cancer|January 17, 2023
Harnessing the MYB-dependent TAL1 5'super-enhancer for targeted therapy in T-ALLCharlotte Smith, Aurore Touzart, Mathieu Simonin, et al.
Leukemia|March 23, 2023
Translocation t(6;7) in AML-M4 cell line GDM-1 results in MNX1 activation through enhancer-hijackingDieter Weichenhan, Anna Riedel, Charlotte Meinen, et al.
Pageof 9